Betterbrand Founder Turns Family Tragedy Into Clinically-Studied Lung Support
Army medic–turned–PharmD launches BetterLungs™ after losing relatives to smoking-related respiratory illnessSAN ANTONIO, Feb. 16, 2026 (GLOBE NEWSWIRE) — Betterbrand, a…
Pharmaceuticals, Biotechnology and Life Sciences
Army medic–turned–PharmD launches BetterLungs™ after losing relatives to smoking-related respiratory illnessSAN ANTONIO, Feb. 16, 2026 (GLOBE NEWSWIRE) — Betterbrand, a…
SAN DIEGO, CA, Feb. 16, 2026 (GLOBE NEWSWIRE) — Sapu Bioscience today announced advancements in its global IP portfolio supporting…
MELVILLE, N.Y., Feb. 13, 2026 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a late stage…
The Put Option Agreement positions Psyence BioMed for potential significant future equity participation in one of the world’s most advanced…
Ocular to host webcast scheduled for Tuesday, February 17, 2026, at 8:00 AM ET Detailed SOL-1 data to be presented…
Joshua Hare Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Executive Chairman, Longeveron Mr. Willard has a 30+…
WEST LAFAYETTE, Ind., Feb. 13, 2026 (GLOBE NEWSWIRE) — Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract…
CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) — Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), a leading formulator, manufacturer, and…
TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics…
REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) — Coherus Oncology, Inc. (“Coherus” or the “Company”) (NASDAQ: CHRS), today announced…